Harvoni Tablets

project

Harvoni Tablets

Primary uses of Harvoni Tablets
Hepatitis C Treatment
Category

Hepatitis C

Brand

Gilead

Ingredent

Sofosbuvir and Ledipasvir Tablets

Strength 400mg And 90mg
Package 28 Tablets

Search Drugs By Manufacturer

Search Drugs By Generic Name

Enquiry For Bulk Order

Product Description

Prices of Harvoni Tablets Distributors, Traders, Exporters & Suppliers

Harvoni is a fixed-dose combination tablet containing ledipasvir and sofosbuvir for oral administration. Ledipasvir is an HCV NS5A inhibitor and sofosbuvir is a nucleotide analog inhibitor of HCV NS5B polymerase.

Doses & Administration

Each tablet contains 90 mg ledipasvir and 400 mg sofosbuvir. Tablets include the following inactive ingredients: colloidal silicon dioxide, copovidone, croscarmellose sodium, lactose monohydrate, magnesium stearate, and microcrystalline cellulose. These tablets are film-coated with a coating material containing the following inactive ingredients: FD&C yellow #6/sunset yellow FCF aluminum lake, polyethylene glycol, polyvinyl alcohol, talc, and titanium dioxide.

It is indicated with or without ribavirin for the treatment of patients with chronic hepatitis C virus (HCV) genotype 1, 4, 5, or 6 infections.

Side Effects:

If Harvoni is administered with ribavirin, refer to the prescribing information for ribavirin for a description of ribavirin-associated adverse reactions. The safety assessment was based on pooled data from three randomized, open-label Phase 3 clinical trials (ION-3, ION-1 and ION-2) of subjects with genotype 1 HCV with compensated liver disease (with and without cirrhosis) including 215, 539, and 326 subjects who received once daily by mouth for 8, 12 and 24 weeks, respectively.

The proportion of subjects who permanently discontinued treatment due to adverse events was 0%, less than 1%, and 1% for subjects receiving these tablets for 8, 12, and 24 weeks, respectively.

The most common adverse reactions (at least 10%) were fatigue and headache in subjects treated with 8, 12, or 24 weeks of Harvoni.

Potential For Drug Interaction

Since Harvoni contains ledipasvir and sofosbuvir, any interaction with these drugs alone may occur.

After oral tablets, sofosbuvir is rapidly absorbed and undergoes extensive extraction of the liver for the first time. In clinical pharmacology studies, sofosbuvir and the inactive metabolite GS-331007 were monitored for pharmacokinetic analysis. Ledipasvir is an inhibitor of the drug transporter P-gp and breast cancer resistance protein (BCRP) and can increase intestinal absorption of the co-administered substrates of these transporters.

Ledipasvir and sofosbuvir are substrates for the drug transporters P-gp and BCRP, while GS-331007 is not. P-gp inducers (such as rifampicin or St. John's wort) reduce the plasma concentrations of ledipasvir and sofosbuvir, resulting in reduced therapeutic effects of Harvoni, and Harvoni is not recommended for use with P-gp inducers.

Category

Hepatitis C

Brand

Gilead

Ingredent

Sofosbuvir and Ledipasvir Tablets

Strength 400mg And 90mg
Package 28 Tablets
Dosage

Tablets

Package Type

Bottle

    • 5.00
    • Tom Joe – Mar 15, 2015:
    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec volutpat purus tempor sem molestie, sed blandit lacus posuere. Lorem ipsum dolor sit amet.
    • 4.00
    • Mark Doe – Jan 23, 2015:
    Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec volutpat purus tempor sem molestie, sed blandit lacus posuere. Lorem ipsum dolor sit amet.

Quick Contact

  • +91-9999098733
  • info@chawlamedicos.com
  • www.chawlamedicos.com
  • +91-9999098733
  • +91-9997777201
  • Chawlamedicos
  • Chawlamedicos

Drugs Details

HARVONI TABLETS is mainly used for the treatment of chronic hepatitis C virus (HCV) infection.

HARVONI TABLETS is a combination tablet containing ledipasvir 90mg and Sofosbuvir 400mg. This drug works by reducing certain enzymes and helps in preventing hepatitis C viral. It improves liver function and reduces the damage.

You need to consult your doctor before taking HARVONI TABLETS during breastfeeding.
•         You need to Avoid drinking alcohol.
•         If you experience any symptoms or illness you must Consult your doctor.
•         Examine your liver function while taking the drug.
•         If you are taking any other drugs along with HARVONI TABLETS, then first you need to consult your doctor.
 

If you miss a dose of HARVONI TABLETS, take it as soon as possible. If there is almost time for your next do not take 2 doses at once. If you miss more than 1 dose, contact your doctor.

The usage of this drug depends upon the age, weight and medical condition of a patient. For the dosage consumption, you need to consult with your doctor. Must remember to take HARVONI TABLETS at the same time each day.

The most common side effect of HARVONI TABLETS are as under:

  • Nausea
  • Vomiting
  • Weight loss
  • Dark-colored urine
  • Diarrhea
  • Insomnia
  • A headache
  • Fatigue